Acute localized
otitis externa (furunculosis) can develop in
the outer third of the ear canal, where skin overlies cartilage and hair follicles
are numerous. As with furunculosis elsewhere on the body, S. aureus is the usual pathogen, and
treatment typically consists of an oral antistaphylococcal penicillin (e.g.,
dicloxacillin), with incision and drainage in cases of abscess formation.
Acute diffuse
otitis externa is also known as “swimmer’s
ear,” although it can develop in the absence of swimming. Heat, humidity, and
the loss of protective cerumen lead to excessive moisture and elevation of the
pH in the ear canal, which in turn lead to skin maceration and irritation.
Infection may then occur; the predominant pathogen is P. aeruginosa, although other
gram-negative and grampositive organisms have been recovered from patients with
this condition. The illness often starts with itching and progresses to severe pain,
which is usually triggered by manipulation of the pinna or tragus. The onset of
pain is usually accompanied by the development of an erythematous, swollen ear
canal, often with scant white, clumpy discharge.
Treatment consists of cleansing the canal to remove debris and to
enhance the activity of topical therapies—usually hypertonic saline or mixtures
of alcohol and acetic acid. Inflammation can also be decreased by adding
glucocorticoids to the treatment regimen or by using Burow’s solution (aluminum
acetate in water). Antibiotics are most effective when given topically. Otic
mixtures provide adequate pathogen coverage; these preparations usually combine
neomycin with polymyxin, with or without glucocorticoids.
Chronic otitis
externa is caused primarily by repeated local irritation, most
commonly arising from persistent drainage from a chronic middle-ear infection.
Other causes of repeated irritation, such as cotton swabs or other foreign
objects inserted into the ear canal, can lead to this condition, as can rare
chronic infections such as syphilis, tuberculosis, or leprosy. Chronic otitis
externa typically presents as erythematous, scaling dermatitis in which the
predominant symptom is pruritus rather than pain; this condition must be
differentiated from several others that produce a similar clinical picture,
such as atopic dermatitis, seborrheic dermatitis, psoriasis, and
dermatomycosis. Therapy consists of identifying and treating or removing the
offending process, although successful resolution is frequently difficult. 7 Infections of the URT 189
Invasive otitis
externa, also known as “malignant” or “necrotizing” otitis
externa, is an aggressive and potentially life-threatening disease that occurs
predominantly in elderly diabetics and other immunocompromised patients. The
disease begins in the external canal, progresses slowly over weeks to months,
and often is difficult to distinguish from a severe case of chronic otitis
externa because of the presence of purulent otorrhea and an erythematous
swollen ear and external canal. Severe, deep-seated otalgia is often noted and
can help differentiate invasive from chronic otitis externa. The characteristic
finding on examination is granulation tissue in the posteroinferior wall of the
external canal, near the junction of bone and cartilage. If left unchecked, the
infection can migrate to the base of the skull (resulting in skullbase osteomyelitis)
and on to the meninges and brain, with a high associated mortality rate.
Cranial nerve involvement is occasionally seen, with the facial nerve usually
affected first and most often. Thrombosis of the sigmoid sinus can occur if the
infection extends to that area. CT, which can reveal osseous erosion of the
temporal bone and skull base, can be used to help determine the extent of
disease, as can gallium and technetium-99 scintigraphy studies. P. aeruginosa is by far the most common
pathogen involved, although S. aureus, Staphylococcus epidermidis, Aspergillus, Actinomyces, and some gram-negative bacteria have been associated with this
disease. Cleansing of the external canal and biopsy of the granulation tissue
within the canal (or of deeper tissues) should be performed in all cases to
isolate the offending organism in culture. Intravenous antibiotic therapy is
directed specifically toward the recovered pathogen. For P. aeruginosa, the regimen typically
includes an antipseudomonal penicillin or cephalosporin (e.g., piperacillin or
ceftazidime) with an aminoglycoside. A fluoroquinolone antibiotic is frequently
used in place of the aminoglycoside and can even be administered orally, given
its excellent bioavailability. Antibiotic drops containing an agent active
against Pseudomonas (e.g.,
ciprofloxacin) are also usually prescribed and are combined with
glucocorticoids to reduce inflammation. Cases of invasive Pseudomonas otitis externa recognized in
the early stages can sometimes be treated with oral and otic fluoroquinolones
alone, albeit with close follow-up. Extensive surgical debridement, once an
important component of the treatment approach, is now rarely indicated.
Source:
Harrison_s_Principles_of_Internal_Medicine_16th_Edition
No comments:
Post a Comment